A global prospective, multi-center, single-arm, post-market clinical follow-up (PMCF) study conducted to assess the performance of the Medina Embolization Device when used in unruptured and ruptured intracranial aneurysms.
Study Type
OBSERVATIONAL
Enrollment
15
Universitätsklinikum Christian Doppler Klinik Salzburg
Salzburg, Austria
Azienda Ospedaliera Ospedale Niguarda Cà Granda
Milan, Italy
Hospital Fundación Jiménez Díaz
Madrid, Spain
Complete aneurysm occlusion as defined by the Modified Raymond-Roy Classification (MRRC)
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.